Healthcare, Pharma, Medical Device etc.
Category
Japan, United states of America, Europe, Rest of World
Geographic Coverage
Video URL
USD1,000,000.00
Sale price (USD)
Not Available
Non-exclusive license price (USD)
USD500,000.00
Exclusive license price (USD)
Not Available
Non-exclusive license royalty rate %
Availability
Patent family
Number of members in the patent family
Assignee(s) / Patent owner(s)
To see the additional information details please login and subscribe to a Premium account.

SOLIAIR™: New Asthma, Bronchitis, COPD and Respiratory Diseases Natural Drug Discovery!

Patent Granted Dear Drug Discovery and Healthcare Investors, <<< >>> I would like to introduce to you my Dietary Supplement for Respiratory and Chronic Lung Diseases (Asthma, COPD, Bronchitis etc.). I believe my product has great potential and a huge market. I would like to explore the possibility of cooperation with you and your company. I am enclosing my presentation and would appreciate your response! <<< >>> SOLIAIR™ Product Overview: <<< >>> SOLIAIR™ is a blend of botanical extracts and a food supplement that contains a unique composition of ingredients, which has reported beneficial impact. SOLIAIR™ can contribute to strengthening the respiratory system and may help patients in chronic respiratory diseases such as Obstructive Lung Disease, Asthma, Bronchitis, COPD (Chronic Obstructive Pulmonary Disease) and other respiratory infections. <<< >>> Patients taking SOLIAIR™ reported a decrease in seasonal infections of the respiratory tract. Reducing the incidence of respiratory infections benefit tremendous potential. The SOLIAIR™ food supplement is free of side effects and has no interaction with conventional medication used for treatment of respiratory disorders! <<< >>> Each SOLIAIR™ food supplement has been authorized and defined by the Israeli Ministry of Health and according to Pharmacists Regulation. The SOLIAIR™ has a patent pending! <<< >>> Market Size Overview: <<< >>> COPD (Chronic Obstructive Pulmonary Disease) and Asthma are Common Diseases and Has No Cure Yet! Respiratory Infections are an important factor and increase the mortality of these diseases. It is estimated that 340 million people worldwide suffer from those diseases. <<< >>> Therapy costs for COPD and its complications totaled in 2006 at $176.8 billion and are expected to rise to $389.2 billion by 2011 and to $832.9 billion by 2021! <<< >>> The SOLIAIR™ Team is Looking for a Person or a Company that: <<< >>> - 1. Handle the Certifications to Sell the Product. - 2. Sell/Market the Product Worldwide. - 3. Direct Sales or Distribution Services Required. <<< >>> Please Contact the SOLIAIR™ Team for More Information: <<< >>> Name: Solomon Jacob (Director/Inventor) e-Mail: solomonj40@gmail.com Company Address: Haifa, 34753 Israel Phone: +972-(0)54-729-5023 Company Presentation: http://goo.gl/6faUeJ <<< >>> Best Regards, SOLIAIR™ Team <<< >>> ** 'Urinary Tract Infections' Natural Therapy Solution Now Available! <<< >>>

$1,000,000 BUY NOW GET LICENSE BROKER APPLY submit an inquiry
photo To see the additional information details please login and subscribe to a Plus or Premium account.